Deliver eConsent to sites and study participants around the globe with confidence
Watch on demand as IQVIA IRT discusses preparing for regulatory inspections. Learn about the latest trends and explore five key areas of regulatory focus to stay ahead in the regulatory landscape.
IQVIA IRT is a randomization and trial supply solution for your site-based or decentralized trial that supports today’s sophisticated trial protocols and ensures the right patient gets the right treatment at the right time:
Reduce time, effort, and cost in drug management by replacing siloed manual processes with the advanced supply and accountability capabilities of IQVIA IRT.
IQVIA scientific and clinical experts understand what it takes to deploy sophisticated trials — from study design to delivery and change management.
Learn about strategies for mitigating the complexities of Cell and Gene Therapy trials, while reducing risk and cost.
Published on PharmaPhorum by Cara Woodruff, Director of Product Management, IQVIA IRT
Save upwards of $20,000 a month through automated supply optimization
Improve quality and sustainability while reducing cost and risk
Learn more about how IRT improves quality and efficiencies in medical device trials
Published on Technology Networks Drug Discovery
By Maxime Schuchewytsch, Associate Director of Product Management, Cenduit IRT, an IQVIA Business
Published on MedHealth Outlook
Interoperable technology that improves data quality and usability while optimizing trial conduct
Deliver eConsent to sites and study participants around the globe with confidence
Improve study quality, accelerate decision making and reduce site and sponsor burden by harnessing the power of IQVIA’s integrated Interactive Response Technology (IRT) and electronic Clinical Outcome Assessment (eCOA) solution.
Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.